A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
Recruiting · NCT06830863 · Registry updated 2026-02-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity | EGFR Inhibitor-associated Rash | Recruiting | Phase 1 / Phase 2 | 2026-02-11 | NCT06830863 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Azitra Inc. | 1 |
| Prosoft Clinical | 2 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Genesis Cancer and Blood Institute | Hot Springs | United States | 10 |
| Inova Schar Cancer | Fairfax | United States | 8 |
| MD Anderson | Houston | United States | 56 |
| NYU Langone | New York | United States | 34 |
| The Ohio State University | Gahanna | United States | 2 |
| Yale University School of Medicine | New Haven | United States | 44 |